GeneDx Holdings Corp. (WGS)
Sector: Healthcare
Industry: Services-Health Services
Country: United States
Exchange: NASDAQ
Market cap: $2.05B
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.
Latest financial period: June 30, 2026
Filed with the SEC: August 3, 2026
Estimated earnings date: October 27, 2026
Profit #1430 of 1484 companies
| | Jun 26 | Mar 26 | Dec 25 | Sep 25 |
|---|
| ROIC | -17.2% | -16.6% | -6.0% | -5.6% |
Growth #735 of 1484 companies
Payout #1117 of 1484 companies
Safety #1130 of 1484 companies
Price #1409 of 1484 companies
